You are here

Article Text

Article menu
Download PDFPDF
PostScript
Letter to the editor
Caution over use of ES2 as a model of ovarian clear cell carcinoma

https://doi.org/10.1136/jclinpath-2014-202430

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Footnotes

    • ALMK and OG-WW contributed equally to this manuscript.

    • Acknowledgements We would like to thank Dr Hiroaki Itamochi for providing ovarian clear cell carcinoma cell lines OVMANA, OVISE and OVSAYO.

    • Contributors Acquisition, analysis and interpretation of data: ALMK, OG-WW, ESYW, OK-LT and K-KC. Drafting the work or revising it critically for important intellectual content: ALMK, OG-WW and AN-YC. Final approval of the version to be published: AN-YC.

    • Funding This study is supported by Health and Medical Research Fund, Food and Health Bureau, Hong Kong Government (ref: 01121526).

    • Competing interests None.

    • Provenance and peer review Not commissioned; externally peer reviewed.